Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001778480-19-000003

Options or other derivatives

  • Director acquired 1,820 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pay Paul William Director 2019-07-26 Grant or award · Stock Option (right to buy) +1,820 32,399 D
Loading xslF345X03/primary_doc.xml…